UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Local drugmakers speed up NASH drug development
by Lee Hye-seon
2019-08-16 13:52
Last trial OKed for Eylea to prevent blindness in premature infants
by Lee Hye-seon
2019-08-13 12:42
Yuhan can continue testing lung cancer drug Lazertinib
by Lee Hye-seon
2019-08-12 12:58
Drug regulator to enhance clinical trial management by 2023
by Lee Hye-seon
2019-08-08 14:55
New weight loss drug Qsymia wins local approval
by Lee Hye-seon
2019-08-01 10:57
라인
One in 45 Koreans prescribed with diet pills
by Lee Hye-seon
2019-07-30 15:44
Rare Fabry disease depicted in K-dramas
by Lee Hye-seon
2019-07-30 12:40
Top-30 makers produce more than half of drugs
by Lee Hye-seon
2019-07-29 16:38
Government employee stages one-person protest against own ministry
by Lee Hye-seon
2019-07-18 17:07
Ministry extends data submission for cell therapy CureSkin
by Lee Hye-seon
2019-07-15 14:35
라인
Ministry to request investigation into Meditoxin approval process
by Lee Hye-seon
2019-07-12 16:29
Acute renal failure reported in ibandronate injections
by Lee Hye-seon
2019-07-11 13:34
Pfizer fails to cut participants in Xeljanz’ post-marketing surveillance
by Lee Hye-seon
2019-07-08 16:39
Kolon confident to resume US trial on Invossa
by Lee Hye-seon
2019-07-04 14:05
Regulator revokes Invossa license; Kolon CEO ‘to fight in court’
by Lee Hye-seon
2019-07-03 11:52
라인
26 new drugs approved in H1
by Lee Hye-seon
2019-07-02 14:31
Multinationals face suspension of drug imports
by Lee Hye-seon
2019-07-01 14:12
Government to help cover costs for injuries from side effects
by Lee Hye-seon
2019-06-28 12:30
Samsung Bioepis readies phase-3 trial on Soliris biosimilar
by Lee Hye-seon
2019-06-27 17:14
False ads of ‘hair loss treatments’ got caught
by Lee Hye-seon
2019-06-27 16:42
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top